甲基苯丙胺的无声损害:视网膜与视网膜微循环的影像学发现
这项前瞻性横断面研究纳入45例慢性甲基苯丙胺使用障碍患者和45例年龄性别匹配的健康对照,采用OCT和OCTA评估视网膜结构与分层微血管灌注。结果显示患者深层毛细血管丛血管密度和脉络膜毛细血管血流面积显著降低,但无临床可见视网膜病变,提示OCTA可检测分层亚临床微血管改变。
要点
- 慢性甲基苯丙胺使用与深层毛细血管丛血管密度显著降低相关。
- 脉络膜毛细血管血流面积在患者组显著降低,但无临床视网膜病变。
- 总RNFL和上方RNFL厚度与用药时长及累积暴露正相关。
核心结论
- 慢性甲基苯丙胺使用与深层毛细血管丛血管密度降低和脉络膜毛细血管血流减少相关,尽管无临床可见视网膜病变。
- 这些发现提示OCTA可检测到分层特异性亚临床微血管改变。
研究设计与样本
- 前瞻性横断面研究,纳入45例甲基苯丙胺使用障碍患者和45例年龄性别匹配的健康对照。
- 所有参与者接受全面眼科检查及标准化OCT和OCTA成像。
主要发现
- 甲基苯丙胺组总RNFL厚度和上方象限RNFL厚度显著高于对照组(分别为p=0.039和p=0.030)。
- 甲基苯丙胺组深层毛细血管丛血管密度在总区域、旁中心凹和中心凹周围区域均显著降低(均p<0.001)。
- 甲基苯丙胺组脉络膜毛细血管血流面积显著降低(p=0.001)。
- 浅层毛细血管丛血管密度在甲基苯丙胺组较低,但差异无统计学意义(p>0.05)。
- 患者组未观察到临床视网膜病变体征。
关键数值与推荐
- 总RNFL和上方RNFL厚度与用药时长及累积甲基苯丙胺暴露呈正相关(p<0.05)。
- 外层视网膜血流与用药时长及累积甲基苯丙胺暴露呈负相关(p<0.05)。
临床怎么用
- 对慢性甲基苯丙胺使用障碍患者,即使眼底检查无异常,可考虑OCTA评估深层毛细血管丛和脉络膜毛细血管灌注。
- RNFL厚度变化和 outer retinal flow 可作为评估用药时长和累积暴露的潜在影像学标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate retinal structural parameters and layer-specific microvascular perfusion using optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) in patients with chronic methamphetamine use disorder. METHODS: This prospective, cross-sectional study included 45 patients with methamphetamine use disorder and 45 age-and sex-matched healthy controls. All participants underwent comprehensive ophthalmologic examination and standardized OCT and OCTA imaging. Central macular thickness, peripapillary retinal nerve fiber layer (RNFL) thickness, and subfoveal choroidal thickness were assessed by OCT. OCTA was used to quantify foveal avascular zone (FAZ) area, vessel density of the superficial and deep capillary plexuses (SCP and DCP), and flow areas of the outer retina and choriocapillaris. Correlations with duration and cumulative methamphetamine exposure were analyzed. RESULTS: Total and superior quadrant RNFL thicknesses were significantly higher in the methamphetamine group(p=0.039 and p=0.030, respectively). Although SCP-VD was lower in the methamphetamine group, this difference did not reach statistical significance(p>0.05). In contrast, DCP-VD was significantly reduced in the methamphetamine group across total, parafoveal, and perifoveal regions(all p<0.001). Choriocapillaris flow area was also significantly lower in methamphetamine users(p=0.001). No clinical signs of retinopathy were observed in the patient group. Total and superior RNFL thicknesses were positively correlated, and outer retinal flow was negatively correlated, with both duration and cumulative methamphetamine exposure(p<0.05). CONCLUSION: Chronic methamphetamine use was associated with reduced DCP vessel density and decreased choriocapillaris flow despite the absence of clinically apparent retinopathy. These findings suggest layer-specific subclinical microvascular alterations detectable by OCTA. Longitudinal studies are needed to determine their progression and clinical relevance.
引用
- Sahin S, Nalcaci S, Cicek M, et al. The Silent Damage of Methamphetamine: Imaging-Based Findings in the Retina and Retinal Microcirculation. Retina. 2026. PMID: 42530460. doi:10.1097/IAE.0000000000004942
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。